Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...
The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...
Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.
Discover how AI is transforming biologics discovery, tackling adoption challenges, and driving growth in the biologics market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results